Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04202133 · ClinicalTrials.gov registry record · Phase 4
Neurocognitive Benefits of a Weight Management Program
A Phase 4 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 61
- Enrollment target
NCT04202133: Completed Phase 4 study, sponsored by University of Pennsylvania.
NCT04202133 is a Phase 4 study that has completed, run by University of Pennsylvania. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04202133, a Phase 4 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 61 participants
- Enrollment target
Study Summary
This study will assess whether weight loss induced through diet and physical activity can change neural responses to high- and low-calorie food images. In addition, it will evaluate whether weight loss can improve neural function when performing the N-back task, a measure of working memory. Findings will address notable gaps in the literature by testing whether a scalable weight loss intervention can help protect and improve neurocognitive functioning and brain health in individuals with obesity. This study will also provide important information about the effects of weight loss on neuroplasticity in brain regions crucial for memory and cognitive functioning, which will help to inform future interventions aimed at promoting brain health.
Interventions
- BEHAVIORAL Waitlist
- BEHAVIORAL WW (formerly Weight Watchers)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2019-11-20 |
| Est. Completion | 2021-07-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04202133
The ClinicalTrials.gov registry entry for NCT04202133 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Waitlist is the first listed.
NCT04202133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04202133 about?
NCT04202133 is a clinical study titled "Neurocognitive Benefits of a Weight Management Program". This study will assess whether weight loss induced through diet and physical activity can change neural responses to high- and low-calorie food images. In addition, it will evaluate whether weight loss can improve neural function when performing the N-back task, a measure of working memory. Findings...
What is the current status of trial NCT04202133?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2019-11-20. Estimated completion is 2021-07-20.
What interventions are being tested in trial NCT04202133?
The interventions under investigation include: Waitlist (BEHAVIORAL), WW (formerly Weight Watchers) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04202133?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.